Background Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year
survival rate of around 1%. Treatment with Viscum album L.(VA) extracts has been shown to …

Objective: To analyze the financial burden of complementary and alternative medicine
(CAM) in cancer treatment. Materials and Methods: Based on a systematic search of the …

Background: Newer personalized medicines including targeted therapies such as PARP
inhibitors and CDK 4/6 inhibitors have been shown to improve the survival of breast and …

Background Despite improvement of tumour response rates in patients with progressive and
metastatic cancer, immune checkpoint inhibitors (ICM) induce toxicities in cancer patients …

Background Lung cancer (LC) is associated with high mortality and poor quality of life (QoL).
The disease as well as oncological treatments such as radiation and chemotherapy with …

Background. In Europe, mistletoe extracts are widely used as a complementary cancer
therapy. We assessed the safety of subcutaneous mistletoe as a conjunctive therapy in …

Introduction: Viscum album L extracts (VA) are frequently used in integrative oncology. Aim
of this study was to evaluate the impact of add-on VA applications on various patient …

Background. Intratumoral (IT) injection of European mistletoe (Viscum album L) preparations
might induce local tumor response through combined cytotoxic and immunomodulatory …

Background Pancreatic cancer has a dire prognosis and is associated with a high mortality.
Palliative patients have special needs and often seek help in integrative oncological …

Background. Traditional mistletoe therapy in cancer patients involves subcutaneous
applications of Viscum album L. preparations, with doses slowly increasing based on patient …